157 related articles for article (PubMed ID: 31953437)
1. Development and application of two novel monoclonal antibodies against overexpressed CD26 and integrin α3 in human pancreatic cancer.
Arias-Pinilla GA; Dalgleish AG; Mudan S; Bagwan I; Walker AJ; Modjtahedi H
Sci Rep; 2020 Jan; 10(1):537. PubMed ID: 31953437
[TBL] [Abstract][Full Text] [Related]
2. Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer.
Arias-Pinilla GA; Dalgleish AG; Mudan S; Bagwan I; Walker AJ; Modjtahedi H
Oncotarget; 2018 Apr; 9(28):19994-20007. PubMed ID: 29731998
[TBL] [Abstract][Full Text] [Related]
3. Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens.
Hatano R; Yamada T; Madokoro H; Otsuka H; Komiya E; Itoh T; Narita Y; Iwata S; Yamazaki H; Matsuoka S; Dang NH; Ohnuma K; Morimoto C
PLoS One; 2019; 14(6):e0218330. PubMed ID: 31194830
[TBL] [Abstract][Full Text] [Related]
4. Establishment of monoclonal anti-human CD26 antibodies suitable for immunostaining of formalin-fixed tissue.
Hatano R; Yamada T; Matsuoka S; Iwata S; Yamazaki H; Komiya E; Okamoto T; Dang NH; Ohnuma K; Morimoto C
Diagn Pathol; 2014 Feb; 9():30. PubMed ID: 24502396
[TBL] [Abstract][Full Text] [Related]
5. Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer.
Ke FY; Chen WY; Lin MC; Hwang YC; Kuo KT; Wu HC
Cancer Sci; 2020 Oct; 111(10):3478-3492. PubMed ID: 32648337
[TBL] [Abstract][Full Text] [Related]
6. Blockade of integrin α3 attenuates human pancreatic cancer via inhibition of EGFR signalling.
Lee J; Lee J; Choi C; Kim JH
Sci Rep; 2019 Feb; 9(1):2793. PubMed ID: 30808960
[TBL] [Abstract][Full Text] [Related]
7. Nuclear localization of CD26 induced by a humanized monoclonal antibody inhibits tumor cell growth by modulating of POLR2A transcription.
Yamada K; Hayashi M; Madokoro H; Nishida H; Du W; Ohnuma K; Sakamoto M; Morimoto C; Yamada T
PLoS One; 2013; 8(4):e62304. PubMed ID: 23638030
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
[TBL] [Abstract][Full Text] [Related]
9. CD26/dipeptidyl peptidase IV as a novel therapeutic target for cancer and immune disorders.
Thompson MA; Ohnuma K; Abe M; Morimoto C; Dang NH
Mini Rev Med Chem; 2007 Mar; 7(3):253-73. PubMed ID: 17346218
[TBL] [Abstract][Full Text] [Related]
10. A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target.
Ohnuma K; Hatano R; Komiya E; Otsuka H; Itoh T; Iwao N; Kaneko Y; Yamada T; Dang NH; Morimoto C
Front Biosci (Landmark Ed); 2018 Jun; 23(9):1754-1779. PubMed ID: 29772527
[TBL] [Abstract][Full Text] [Related]
11. Identification of the target of monoclonal antibody A6H as dipeptidyl peptidase IV/CD26 by LC MS\MS.
Hass GM; Meyer JL; Newitt RA; Labuda T; Brown L; Aebersold R; Vessella RL
Hybridoma; 2001 Aug; 20(4):231-6. PubMed ID: 11604108
[TBL] [Abstract][Full Text] [Related]
12. A novel inhibitory anti-invasive MAb isolated using phenotypic screening highlights AnxA6 as a functionally relevant target protein in pancreatic cancer.
O'Sullivan D; Dowling P; Joyce H; McAuley E; McCann A; Henry M; McGovern B; Barham P; Kelleher FC; Murphy J; Kennedy S; Swan N; Moriarty M; Clynes M; Larkin A
Br J Cancer; 2017 Oct; 117(9):1326-1335. PubMed ID: 28881357
[TBL] [Abstract][Full Text] [Related]
13. The alpha2 and alpha3 integrins are required for morphologic differentiation of an intestinal epithelial cell line.
Zhang X; Cromwell JW; Kunjummen BD; Yee D; Garcia-Aguilar J
Surgery; 2003 Apr; 133(4):429-37. PubMed ID: 12717361
[TBL] [Abstract][Full Text] [Related]
14. In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.
Larbouret C; Robert B; Navarro-Teulon I; Thèzenas S; Ladjemi MZ; Morisseau S; Campigna E; Bibeau F; Mach JP; Pèlegrin A; Azria D
Clin Cancer Res; 2007 Jun; 13(11):3356-62. PubMed ID: 17545543
[TBL] [Abstract][Full Text] [Related]
15. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
16. Establishment of H
Yamada S; Itai S; Nakamura T; Chang YW; Harada H; Suzuki H; Kaneko MK; Kato Y
Monoclon Antib Immunodiagn Immunother; 2017 Dec; 36(6):287-290. PubMed ID: 29172998
[TBL] [Abstract][Full Text] [Related]
17. Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL-2, IL-12 or IL-15.
Yamabe T; Takakura K; Sugie K; Kitaoka Y; Takeda S; Okubo Y; Teshigawara K; Yodoi J; Hori T
Immunology; 1997 May; 91(1):151-8. PubMed ID: 9203979
[TBL] [Abstract][Full Text] [Related]
18. Correlation of the epitopes defined by anti-CD26 mAbs and CD26 function.
Dong RP; Tachibana K; Hegen M; Scharpé S; Cho D; Schlossman SF; Morimoto C
Mol Immunol; 1998 Jan; 35(1):13-21. PubMed ID: 9683260
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of CD26/DPPIV in mesothelioma tissue and mesothelioma cell lines.
Amatya VJ; Takeshima Y; Kushitani K; Yamada T; Morimoto C; Inai K
Oncol Rep; 2011 Dec; 26(6):1369-75. PubMed ID: 21894438
[TBL] [Abstract][Full Text] [Related]
20. Development of Splice Variant-Specific Monoclonal Antibodies Against Human α3 Integrin.
Oku T; Ando Y; Ogura M; Tsuji T
Monoclon Antib Immunodiagn Immunother; 2016 Feb; 35(1):12-7. PubMed ID: 26788840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
